Leading science, pioneering therapies

CRM Publications

Found 10 results
Filters: Keyword is Disease Progression  [Clear All Filters]
2015
Vesterinen HM, Connick P, Irvine CMJ, Sena ES, Egan KJ, Carmichael GG, Tariq A, Pavitt S, Chataway J, Macleod MR et al..  2015.  Drug repurposing: a systematic approach to evaluate candidate oral neuroprotective interventions for secondary progressive multiple sclerosis.PLoS One. 10(4):e0117705.
2013
Foley PL, Vesterinen HM, Laird BJ, Sena ES, Colvin LA, Chandran S, Macleod MR, Fallon MT.  2013.  Prevalence and natural history of pain in adults with multiple sclerosis: systematic review and meta-analysis.Pain. 154(5):632-42.
Münzel EJolanda, Wimperis JZ, Williams AC.  2013.  Relapsing-remitting multiple sclerosis and chronic idiopathic neutropenia: a challenging combination.BMJ Case Rep. 2013
2011
Gibbons MA, Mackinnon AC, Ramachandran P, Dhaliwal K, Duffin R, Phythian-Adams AT, van Rooijen N, Haslett C, Howie SE, A Simpson J et al..  2011.  Ly6Chi monocytes direct alternatively activated profibrotic macrophage regulation of lung fibrosis.Am J Respir Crit Care Med. 184(5):569-81.
2010
Anderson JMarian, Patani R, Reynolds R, Nicholas R, Compston A, Spillantini MGrazia, Chandran S.  2010.  Abnormal tau phosphorylation in primary progressive multiple sclerosis.Acta Neuropathol. 119(5):591-600.
2009
Kallis YN, Forbes SJ.  2009.  The bone marrow and liver fibrosis: friend or foe?Gastroenterology. 137(4):1218-21.
Anderson JMarian, Patani R, Reynolds R, Nicholas R, Compston A, Spillantini MGrazia, Chandran S.  2009.  Evidence for abnormal tau phosphorylation in early aggressive multiple sclerosis.Acta Neuropathol. 117(5):583-9.
2008
Natalwala A, Spychal R, Tselepis C.  2008.  Epithelial-mesenchymal transition mediated tumourigenesis in the gastrointestinal tract.World J Gastroenterol. 14(24):3792-7.
Henderson NC, Forbes SJ.  2008.  Hepatic fibrogenesis: from within and outwith.Toxicology. 254(3):130-5.
2002
Prokhortchouk E, Hendrich B.  2002.  Methyl-CpG binding proteins and cancer: are MeCpGs more important than MBDs?Oncogene. 21(35):5394-9.